Thanks to a five-year, $25 million grant, the largest given to the University of Kansas by the National Institutes of Health (NIH), several campus research projects have been funded to promote research development in high priority areas.
0 Comments Click here to read/write comments
Tags: Midwest, Leukemia, Kansas, University of Kansas, Research Funding
Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)
Read More
0 Comments Click here to read/write comments
Tags: CA, Leukemia, new research funding, cancer research, San Diego, SDVS, UCSD, Biotechnology Vendor Showcase, cancer research funding, 2018, AML Research, Acute Myeloid Leukemia
According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.
Read More
0 Comments Click here to read/write comments
Tags: Washington University St. Louis, Washington University, WashU, WUSTL, Leukemia, cancer research, Cancer, Research Funding, biotech vendor show, cancer research funding, Bioresearch Grant, Biotechnology trade show, NIH awards 2017, Cancer Therapeutics, Cancer Immunotherapy
Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.
0 Comments Click here to read/write comments
Tags: Harvard University, Northeast, Leukemia, cancer research, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, longwood, 2016, cancer therapy, Merck
Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, affecting nearly 6 thousand children in the US annually. Recently, a possible relationship has been identified, which may provide valuable insight into why this cancer develops and how to prevent it.
Read More
0 Comments Click here to read/write comments
Tags: Lab Product show, University of Minnesota, UMN, Leukemia, cancer research, Minnesota, University of Minnesota Twin Cities, Minneapolis, MN, UMinn, Minn, Twin Cities, uminn research
Cancer affects the majority of the population in one way or another, through knowing someone with cancer, being exposed to it in the media, or having it oneself. Cancer treatments and cures are some of the most well funded and highly researched areas in the life sciences. Researchers at the Winshop Cancer Institute at Emory University in Atlanta, GA recently discovered that an orange pigment, called parietin or physcion, that is found in lichens and rhubarb has potential to be used as an anti-cancer drug.
0 Comments Click here to read/write comments
Tags: Emory University, Leukemia, cancer research, Southern, Cancer Treatment, Emory, BioResearch Product Faire Event, Atlanta, GA, Southern Region, 2016, Parietin, physcion
Scientists from UC San Francisco and Oregon Health & Science University (OHSU) have teamed up to tackle acute lymphoblastic leukemia (ALL), a blood cancer that typically affects children from two to five years old.
0 Comments Click here to read/write comments
Tags: CA, Leukemia, Oregon Health and Science University, cancer research, Oregon, California, Pediatric Cancer Research, 2015, San Francisco, SFVS, BioResearch Product Faire Event, OR, UCSF, OHSU, Portland, UC San Francisco, Biotechnology Vendor Showcase Event
When life gives you lemons, make lemonade… and if you’ve got lemonade, make a lemonade stand. However, when Alex’s Lemonade Stand Foundation gives you millions in research funding, now you can help cure childhood cancer. Thanks to a little girl who once made lemonade to raise money for childhood cancer research, two UC San Francisco faculty members are among researchers being nationally acknowledged for their work in pediatric oncology.
0 Comments Click here to read/write comments
Tags: CA, Bioresearch funding, Leukemia, California, Pediatric Cancer Research, grants, 2015, Biotechnology, Life Science, UCSF, San Francisco at Mission Bay, cancer research funding, Biotechnology Vendor Showcase Event
Memorial Sloan-Kettering Cancer Center cell engineering researchers and their clinician colleagues have been in the news recently for a successful experimental cell therapy. Called targeted immunotherapy, a patient's T cells are genetically altered in the lab, then reintroduced with the directive to target and kill cancer cells. The treatment was carried out on a group of adults who all suffered from a rapidly progressing form of leukemia that had not responded to chemotherapy. All five went into remission after the novel cell treatment, and three have stayed that way for a number of months. Results of the ongoing clinical trial appeared in the March 20 online edition of the journal Science Translational Medicine, along with an article in the New York Times.
0 Comments Click here to read/write comments
Tags: 2014, Rockefeller University, 2013, Northeast, Leukemia, immunotherapy, cancer research, New York, Memorial Sloan-Kettering Cancer Center, Cancer Treatment, Immune System, Cell Research, RockU, BioResearch Product Faire Event, NY, New York City, MSKCC